Apoptosis: Programmed cell death at a molecular level
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kerr, 1972, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer, 26, 239, 10.1038/bjc.1972.33
Aupperle, 1998, Regulation of synoviocytes proliferation, apoptosis, and invasion by the p53 tumor suppressor gene, Am J Pathol, 152, 1091
Vaux, 2000, Apoptosis genes and autoimmunity, Curr Opin Immunol, 12, 719, 10.1016/S0952-7915(00)00168-0
Fields, 2001, Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells, J Immunol, 167, 2370, 10.4049/jimmunol.167.4.2370
Green, 1999, Killers or clean-up crew. How central are the central mechanisms of apoptosis, 157
Reis e Sousa, 2001, Dendritic cells as sensors of infection, Immunity, 14, 495, 10.1016/S1074-7613(01)00136-4
Griffith, 1995, Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189, 10.1126/science.270.5239.1189
Bellgrau, 1995, A role for CD95 ligand in preventing graft rejection, Nature, 377, 630, 10.1038/377630a0
Restifo, 2000, Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape, Nature Med, 6, 493, 10.1038/74955
Ashkenazi, 1998, Death receptors: signaling and modulation, Science, 281, 1305, 10.1126/science.281.5381.1305
Waterhouse, 1998, Calpain activation is upstream of caspases in radiation-induced apoptosis, Cell Death Differ, 5, 1051, 10.1038/sj.cdd.4400425
Guicciardi, 2000, Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c, J Clin Invest, 106, 1127, 10.1172/JCI9914
Jellinger, 2000, The enigma of cell death in neurodenerative disorders, J Neural Transm, 60, S21
Sheridan, 1997, Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors, Science, 277, 818, 10.1126/science.277.5327.818
Itoh, 1991, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell, 66, 24, 10.1016/0092-8674(91)90614-5
Tartaglia, 1993, A novel domain within the 55 kd TNF receptor signals cell death, Cell, 74, 845, 10.1016/0092-8674(93)90464-2
Suda, 1993, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell, 75, 1169, 10.1016/0092-8674(93)90326-L
Tanaka, 1995, Expression of the functional soluble form of human fas ligand in activated lymphocytes, EMBO J, 14, 1129, 10.1002/j.1460-2075.1995.tb07096.x
Pimentel-Muinos, 1999, Regulated commitment of TNF receptor signaling: a molecular switch for death or activation, Immunity, 11, 783, 10.1016/S1074-7613(00)80152-1
Wallach, 1999, Tumor necrosis factor receptor and Fas signaling mechanisms, Annu Rev Immunol, 17, 331, 10.1146/annurev.immunol.17.1.331
Chinnaiyan, 1996, FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis, J Biol Chem, 271, 4961, 10.1074/jbc.271.9.4961
Muzio, 1996, FLICE, a novel FADD-homologous ICE/CED-3-like signaling protease, is recruited to the CD95 (FAS/APO-1) death-inducing complex, Cell, 85, 817, 10.1016/S0092-8674(00)81266-0
Telliez, 2000, Mutational analysis and NMR studies of the death domain of the tumor necrosis factor receptor-1, J Mol Biol, 300, 1323, 10.1006/jmbi.2000.3899
Yeh, 1998, FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis, Science, 279, 1954, 10.1126/science.279.5358.1954
Lünemann, 2002, Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto) antigen-specific T cells, J Immunol, 168, 4881, 10.4049/jimmunol.168.10.4881
Enari, 1998, A caspase-activated DNAase that degrades DNA during apoptosis, and its inhibitor ICAD, Nature, 391, 43, 10.1038/34112
Sakahira, 1998, Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis, Nature, 391, 96, 10.1038/34214
Hannun, 1997, Apoptosis and the dilemma of cancer chemotherapy, Blood, 89, 1845, 10.1182/blood.V89.6.1845
Irmler, 1997, Inhibition of death receptor signals by cellular FLIP, Nature, 388, 190, 10.1038/40657
Thome, 1997, Viral FLICE-inhibitory proteins (FLIPS) prevent apoptosis induced by death receptors, Nature, 386, 517, 10.1038/386517a0
Scaffidi, 1999, The role of c-FLIP in modulation of CD95-induced apoptosis, J Biol Chem, 274, 1541, 10.1074/jbc.274.3.1541
Tepper, 1999, Modulation of caspase-8 and FLICE-inhibitor inhibitor protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma, Blood, 94, 1727, 10.1182/blood.V94.5.1727
Li, 1998, Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis, Cell, 94, 491, 10.1016/S0092-8674(00)81590-1
Ghafourifar, 1999, Ceramide induces cytochrome c release from isolated mitochondria, J Biol Chem, 274, 6080, 10.1074/jbc.274.10.6080
Chai, 2000, Structural and biochemical basis of apoptotic activation by Smac/DIABLO, Nature, 406, 855, 10.1038/35022514
Susin, 1996, Bcl-2 inhibits the mitochondrial release of an apoptogenic protease, J Exp Med, 184, 1331, 10.1084/jem.184.4.1331
Susin, 1997, The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis, J Exp Med, 186, 25, 10.1084/jem.186.1.25
Liu, 1996, Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c, Cell, 86, 147, 10.1016/S0092-8674(00)80085-9
Monaghan, 1992, Ultrastructural localization of bcl-2 protein, J Histochem Cytochem, 40, 1819, 10.1177/40.12.1453000
Krajewski, 1993, Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes, Cancer Res, 53, 4701
de Jong, 1994, Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells, Cancer Res, 54, 256
Li, 1997, Cytochrome c and dATP-dependent formation of Apaf-1/caspase 9 complex initiates an apoptotic protease cascade, Cell, 91, 479, 10.1016/S0092-8674(00)80434-1
Cleary, 1986, Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation, Cell, 47, 19, 10.1016/0092-8674(86)90362-4
Seto, 1988, Alternative promoters and exons, somatic mutation and transcriptional deregulation of the Bcl-2 fusion gene in lymphoma, EMBO J, 7, 123, 10.1002/j.1460-2075.1988.tb02791.x
Vaux, 1988, Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells, Nature, 335, 440, 10.1038/335440a0
Jäättelä, 1999, Escaping cell death: survival proteins in cancer, Exp Cell Res, 248, 30, 10.1006/excr.1999.4455
Akao, 1994, Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membranes and mitochondrial membranes, Cancer Res, 54, 2468
Adams, 1998, The bcl-2 protein family: arbiters of cell survival, Science, 281, 1322, 10.1126/science.281.5381.1322
Hengartner, 1992, elegans gene ced-9 protects cells from programmed cell death, Nature (London), 356, 494, 10.1038/356494a0
Cory, 1999, Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation, Cancer Res, 59, 1685S
Leuenroth, 2000, The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis, J Leukoc Biol, 68, 158, 10.1189/jlb.68.1.158
Moulding, 1998, Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival, Blood, 92, 2495, 10.1182/blood.V92.7.2495
Chuang, 1998, A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils, Biochem Biophys Res Commun, 249, 361, 10.1006/bbrc.1998.9155
Orlofsky, 1999, The murine antiapoptotic protein A1 is induced in inflammatory macrophages and constitutively expressed in neutrophils, J Immunol, 163, 412, 10.4049/jimmunol.163.1.412
Hatakeyama, 1998, Multiple gene duplication and expression of mouse bcl-2 related genes, A1. Int Immunol, 10, 631, 10.1093/intimm/10.5.631
Lin, 1993, Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2, J Immunol, 151, 1979, 10.4049/jimmunol.151.4.1979
Orlofsky, 2002, Deficiency in the anti-apoptotic protein A1-a results in a diminished acute inflammatory response, J Immunol, 168, 1840, 10.4049/jimmunol.168.4.1840
Hockenberg, 1990, Bcl2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature (London), 348, 334, 10.1038/348334a0
Oltvai, 1993, Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death, Cell, 74, 609, 10.1016/0092-8674(93)90509-O
Korsmeyer, 1999, Bcl-2 gene family and the regulation of programmed cell death, Cancer Res, 59, 1693S
Yang, 1997, Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science, 275, 1129, 10.1126/science.275.5303.1129
Li, 1997, Cytochrome c and dATP-dependent formation of Apaf-1/caspase 9 complex initiates an apoptotic protease cascade, Cell, 91, 479, 10.1016/S0092-8674(00)80434-1
Cai, 1998, Mitochondrial control of apoptosis: the role of cytochrome c, Biochim Biophys Acta, 1366, 139, 10.1016/S0005-2728(98)00109-1
Pellegrini, 1999, A portrait of the Bcl-2 protein family: life, death, and the whole picture, J Clin Immunol, 19, 365, 10.1023/A:1020598632068
Zhu, 1996, Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types, EMBO J, 15, 4130, 10.1002/j.1460-2075.1996.tb00788.x
Kelekar, 1998, Bcl-2 family proteins: the role of the BH3 domain in apoptosis, Trends Cell Biol, 8, 324, 10.1016/S0962-8924(98)01321-X
Adams, 1998, The Bcl-2 protein family: arbiters of cell survival, Science, 281, 1322, 10.1126/science.281.5381.1322
Borner, 1994, Dissection of functional domains in Bcl-2 alpha by site-directed mutagenesis, Biochem Cell Biol, 72, 463, 10.1139/o94-062
Yin, 1994, BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature, 369, 321, 10.1038/369321a0
Farrow, 1996, New members of the Bcl-2 family and their protein partners, Curr Opin Genet Dev, 6, 45, 10.1016/S0959-437X(96)90009-X
Chittenden, 1995, A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions, EMBO J, 14, 5589, 10.1002/j.1460-2075.1995.tb00246.x
Huang, 1998, The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4, EMBO J, 17, 1029, 10.1093/emboj/17.4.1029
McDonnell, 1999, Solution structure of the pro-apoptotic molecule Bid: A structural basis for apoptotic agonists and antagonists, Cell, 96, 625, 10.1016/S0092-8674(00)80573-5
Shibasaki, 1997, Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2, Nature, 386, 728, 10.1038/386728a0
Yang, 1996, Molecular thanatopsis: a discourse on the BCL2 family and cell death, Blood, 88, 386, 10.1182/blood.V88.2.386.bloodjournal882386
Ayllon, 2002, Segregation of Bad from lipid rafts is implicated in the induction of apoptosis, J Immunol, 168, 3387, 10.4049/jimmunol.168.7.3387
Brown, 1998, Functions of lipid rafts in biological membranes, Annu Rev Cell Dev Biol, 14, 111, 10.1146/annurev.cellbio.14.1.111
Cottin, 2002, Restricted localization of the TNF receptor CD120a to lipid rafts: a novel role for the death domain, J Immunol, 168, 4095, 10.4049/jimmunol.168.8.4095
Tsujimoto, 2000, Bcl-2 family: life or death switch, FEBS Lett, 466, 6, 10.1016/S0014-5793(99)01761-5
Silverman, 2001, NF-κB signaling pathways in mammalian and insect innate immunity, Genes Dev, 15, 2321, 10.1101/gad.909001
Rayet, 1999, Aberrant rel/nfkb genes and activity in human cancer, Oncogene, 18, 6938, 10.1038/sj.onc.1203221
Karin, 2002, NF-κB in cancer: from innocent bystander to major culprit, Natur Rev Cancer, 2, 301, 10.1038/nrc780
Davis, 2001, Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells, J Exp Med, 194, 1861, 10.1084/jem.194.12.1861
Wang, 1998, NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation, Science, 281, 1680, 10.1126/science.281.5383.1680
Ravi, 2001, Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB, Nat Cell Biol, 3, 409, 10.1038/35070096
Kerr, 1972, Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics, Br J Cancer, 26, 239, 10.1038/bjc.1972.33
Wyllie, 1984, Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis, J Pathol, 142, 67, 10.1002/path.1711420112
Sakahira, 1998, Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis, Nature, 391, 96, 10.1038/34214
Gavrieli, 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J Cell Biol, 119, 493, 10.1083/jcb.119.3.493
Daryzynkiewicz, 1992, Features of apoptotic cells measured by flow cytometry, Cytometry, 13, 795, 10.1002/cyto.990130802
Gold, 1993, Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections, J Histochem Cytochem, 41, 1023, 10.1177/41.7.8515045
Gorczyca, 1993, Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays, Cancer Res, 52, 1945
Li, 1995, Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation, Cell Prolif, 28, 571, 10.1111/j.1365-2184.1995.tb00045.x
Li, 1995, Single-step procedure for labeling DNA strand breaks with fluorescein- or BODIPY-conjugated deoxynucleotides: detection of apoptosis and bromodeoxyuridine incorporation, Cytometry, 20, 172, 10.1002/cyto.990200210
Grasl-Kraipp, 1995, In situ detection of fragmented DNA (TUNEL) fails to discriminate among apoptosis, necrosis and autolytic cell death: a cautionary note, Hepatology, 21, 1465
Charriaut-Marlangue, 1995, A cautionary note on the use of TUNEL to determine apoptosis, NeuroReport, 7, 61, 10.1097/00001756-199512000-00014
Didenko, 1996, Presence of double-stranded DNA breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis, J Cell Biol, 135, 1369, 10.1083/jcb.135.5.1369
Stadelmann, 1998, Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis, Neuropathol Exp Neurol, 57, 456, 10.1097/00005072-199805000-00009
Willingham, 1999, Cytochemical methods for the detection of apoptosis, J Histochem Cytochem, 47, 1101, 10.1177/002215549904700901
Frankfurt, 1996, Monoclonal antibody to single stranded DNA is a specific and sensitive cellular marker of apoptosis, Exp Cell Res, 226, 387, 10.1006/excr.1996.0240
Frankfurt, 2001, Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening, Immunol Methods, 253, 133, 10.1016/S0022-1759(01)00387-8
Frankfurt, 2001, Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin, J Histochem Cytochem, 49, 369, 10.1177/002215540104900311
Smyth, 2002, Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system, Biol Tech, 32, 648
Bradbury, 2000, Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis, J Immunol Methods, 240, 79, 10.1016/S0022-1759(00)00178-2
Andree, 1990, Binding of vascular anticoagulant α (VACα) to planer phospholipids bilayers, J Biol Chem, 265, 4923, 10.1016/S0021-9258(19)34062-1
Fadok, 1992, Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages, J Immunol, 148, 2207, 10.4049/jimmunol.148.7.2207
Vermes, 1995, A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled annexin V, J Immunol Methods, 184, 39, 10.1016/0022-1759(95)00072-I
Hirsch, 1997, The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death, Oncogene, 15, 1573, 10.1038/sj.onc.1201324
Packard, 2001, Caspase 8 activity in membrane blebs after anti-Fas ligation, J Immunol, 167, 5061, 10.4049/jimmunol.167.9.5061
Liu, 1996, Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c, Cell, 12, 147, 10.1016/S0092-8674(00)80085-9
Budihardjo, 1999, Biochemical pathways of caspase activation during apoptosis, Annu Rev Cell Dev Biol, 15, 269, 10.1146/annurev.cellbio.15.1.269
Chan, 1999, Caspase and calpain substrates: roles in synaptic plasticity and cell death, J Neurosci Res, 58, 167, 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K
Dive, 1992, Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry, Biochim Biophys Acta, 1133, 275, 10.1016/0167-4889(92)90048-G
Darzynkiewicz, 1997, Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis), Cytometry, 27, 1, 10.1002/(SICI)1097-0320(19970101)27:1<1::AID-CYTO2>3.0.CO;2-L
Gao, 1998, Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis, J Exp Med, 188, 887, 10.1084/jem.188.5.887
Antonsson, 1997, Inhibition of BAX channel-forming activity by Bcl-2, Science, 277, 370, 10.1126/science.277.5324.370
Bradham, 1998, The mitochondrial permeability transition is required for tumor necrosis factor α-mediated apoptosis and cytochrome c release, Mol Cell Biol, 18, 6353, 10.1128/MCB.18.11.6353
Fadok, 1992, Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells, J Immunol, 149, 4029, 10.4049/jimmunol.149.12.4029
Martin, 1995, Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and abl, J Exp Med, 182, 1545, 10.1084/jem.182.5.1545
Wyllie, 1980, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation, Nature, 284, 555, 10.1038/284555a0
Godman, 1975, Action of cytochalasin D on cells of established lines. Zeiosis and movement at the cell surface, J Cell Biochem, 64, 644
Casciola-Rosen, 1994, Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes, J Exp Med, 179, 1317, 10.1084/jem.179.4.1317
Savill, 1997, Recognition and phagocytosis of cells undergoing apoptosis, Br Med Bull, 53, 491, 10.1093/oxfordjournals.bmb.a011626
Albert, 1998, Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes, J Exp Med, 188, 1359, 10.1084/jem.188.7.1359
Sauter, 2000, Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells, J Exp Med, 191, 423, 10.1084/jem.191.3.423
Schuler, 1985, Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro, J Exp Med, 161, 526, 10.1084/jem.161.3.526
Sallusto, 1995, Dendritic cells use macropinocytosis and the mannose receptor to concentrate antigen in the MHC class II compartment. Down regulation by cytokines and bacterial products, J Exp Med, 182, 389, 10.1084/jem.182.2.389
Huang, 2000, A discreet subpopulation of dendritic cells transports apoptotic intestinal epidermal cells to T cell areas of mesenteric lymph nodes, J Exp Med, 191, 435, 10.1084/jem.191.3.435
Thomson, 1999, Are dendritic cells the key to liver transplant tolerance, Immunol Today, 20, 27, 10.1016/S0167-5699(98)01378-4
Guermonprez, 2002, Antigen presentation and T cell stimulation by dendritic cells, Annu Rev Immunol, 20, 621, 10.1146/annurev.immunol.20.100301.064828
Surh, 1994, T cell apoptosis detected in situ during positive and negative selection in the thymus, Nature, 372, 100, 10.1038/372100a0
Sallusto, 1996, Ceramide inhibits antigen uptake and presentation by dendritic cells, J Exp Med, 184, 2411, 10.1084/jem.184.6.2411
O'Doherty, 1993, Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium, J Exp Med, 178, 1067, 10.1084/jem.178.3.1067
Grabbe, 2000, Dendritic cells: multi-lineal and multi-functional, Immunology Today, 21, 431, 10.1016/S0167-5699(00)01694-7
Steinman, 2000, The induction of tolerance by dendritic cells that have captured apoptotic cells, J Exp Med, 191, 411, 10.1084/jem.191.3.411
Banchereau, 2000, Immunobiology of dendritic cells, Annu Rev Immunol, 18, 767, 10.1146/annurev.immunol.18.1.767
Albert, 1998, Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs, Nature, 392, 86, 10.1038/32183
Drickamer, 1999, C type lectin like domains, Curr Opin Struct Biol, 9, 585, 10.1016/S0959-440X(99)00009-3
Engering, 2002, Immune escape through C-type lectins on dendritic cells, Trends Immunol, 23, 480, 10.1016/S1471-4906(02)02296-2
Rubartelli, 1997, The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium, Eur J Immunol, 27, 1893, 10.1002/eji.1830270812
MacPherson, 1995, Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence, J Immunol, 154, 1317, 10.4049/jimmunol.154.3.1317
DeSmedt, 1996, Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo, J Exp Med, 184, 1413, 10.1084/jem.184.4.1413
Roake, 1995, Dendritic cell loss from non-lymphoid tissues following systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1, J Exp Med, 181, 2237, 10.1084/jem.181.6.2237
Rescigno, 1998, Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells, Proc Natl Acad Sci U S A, 95, 5229, 10.1073/pnas.95.9.5229
Bhardwaj, 1994, Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells, J Clin Invest, 94, 797, 10.1172/JCI117399
Bender, 1998, The distinctive features of influenza virus infection of dendritic cells, Immunobiology, 198, 64, 10.1016/S0171-2985(98)80078-8
Sparwasser, 1998, Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells, Eur J Immunol, 28, 2045, 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8
Cella, 1999, Maturation, activation, and protection of dendritic cells induced by double-stranded RNA, J Exp Med, 189, 821, 10.1084/jem.189.5.821
Verdijk, 1999, Polyriboinosinic polyribocytidylic acid (poly I:C) induces stable maturation of functionally active human dendritic cells, J Immunol, 163, 57, 10.4049/jimmunol.163.1.57
Caux, 1994, Activation of human dendritic cells through CD40 cross-linking, J Exp Med, 180, 1263, 10.1084/jem.180.4.1263
Cella, 1996, Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation, J Exp Med, 184, 747, 10.1084/jem.184.2.747
Heath, 2001, Cross-presentation, dendritic cells, tolerance and immunity, Ann Rev Immunol, 19, 47, 10.1146/annurev.immunol.19.1.47
Gallucci, 1999, Natural adjuvants: endogenous activators of dendritic cells, Nat Med, 11, 1249, 10.1038/15200
Gajewski, 1996, Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization, J Immunol, 156, 2909, 10.4049/jimmunol.156.8.2909
Lechmann, 2002, CD83 on dendritic cells: more than just a marker for maturation, Trends Immunol, 23, 273, 10.1016/S1471-4906(02)02214-7
Gately, 1998, The interleukin-12/interleukin-12 receptor system: role in normal and pathologic immune response, Annu Rev Immunol, 16, 495, 10.1146/annurev.immunol.16.1.495
Trinchieri, 1995, Interleukin 12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance with antigen-specific adaptive immunity, Ann Rev Immunol, 13, 251, 10.1146/annurev.iy.13.040195.001343
Winzler, 1997, Maturation stages of mouse dendritic cells in growth factor-dependent long term cultures, J Exp Med, 185, 317, 10.1084/jem.185.2.317
Nagayama, 2000, IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells, J Immunol, 165, 59, 10.4049/jimmunol.165.1.59
Stuart, 2002, Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation, J Immunol, 168, 1627, 10.4049/jimmunol.168.4.1627
De Smedt, 1998, Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo, J Immunol, 161, 4476, 10.4049/jimmunol.161.9.4476
Ronchese, 2001, Killing of dendritic cells: a life cut short or a purposeful death?, J Exp Med, 194, F23, 10.1084/jem.194.5.F23
Wiley, 1995, Identification and characterization of a new member of the TNF family that induces apoptosis, Immunity, 3, 673, 10.1016/1074-7613(95)90057-8
Pitti, 1996, Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis family cytokine family, J Biol Chem, 271, 12687, 10.1074/jbc.271.22.12687
Pan, 1997, The receptor for the cytotoxic ligand TRAIL, Science, 276, 111, 10.1126/science.276.5309.111
MacFarlane, 1997, Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL, J Biol Chem, 272, 25417, 10.1074/jbc.272.41.25417
Keogh, 2000, Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis, FEBS Lett, 471, 93, 10.1016/S0014-5793(00)01375-2
Wang, 1999, Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II, Cell, 98, 47, 10.1016/S0092-8674(00)80605-4
Ingulli, 1997, In vivo detection of dendritic cell antigen presentation to CD4+ T cells, J Exp Med, 185, 2133, 10.1084/jem.185.12.2133
Timmerman, 1999, Dendritic cell vaccines for cancer immunotherapy, Annu Rev Med, 50, 507, 10.1146/annurev.med.50.1.507
Kirk, 2000, Gene-modified dendritic cells for use in tumor vaccines, Hum Gene Ther, 11, 797, 10.1089/10430340050015419
Hsu, 1996, Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells, Nat Med, 2, 52, 10.1038/nm0196-52
Nestle, 1998, Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells, Nat Med, 4, 328, 10.1038/nm0398-328
Kugler, 2000, Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids, Nat Med, 6, 332, 10.1038/73193
1999, 1
Goddard, 2001, Generation in vitro of B-cell chronic lymphocytic leukemia-proliferative and specific HLA class-II restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumor cell lysate, Clin Exp Immunol, 126, 16, 10.1046/j.1365-2249.2001.01617.x
Sombroek, 2002, Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation, J Immunol, 168, 4333, 10.4049/jimmunol.168.9.4333
Cunnion, 1999, Tumor necrosis factor receptors encoded by poxviruses, Mol Genet Metab, 67, 278, 10.1006/mgme.1999.2878
Clem, 2001, Baculoviruses and apoptosis: the good, the bad and the ugly, Cell Death Differ, 8, 137, 10.1038/sj.cdd.4400821
Medema, 1999, Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein, J Exp Med, 190, 1033, 10.1084/jem.190.7.1033
Glykofrydes, 2000, Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation or pathogenicity, J Virol, 74, 11919, 10.1128/JVI.74.24.11919-11927.2000
Sarid, 1999, Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter, J Virol, 73, 1438, 10.1128/JVI.73.2.1438-1446.1999
Kreuz, 2001, NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling, Mol Cell Biol, 21, 3964, 10.1128/MCB.21.12.3964-3973.2001
Ambinder, 2000, Gammaherpesviruses and “hit-and-run” oncogenesis, Am J Pathol, 156, 1, 10.1016/S0002-9440(10)64697-4
Keller, 2000, Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells, Blood, 96, 2537, 10.1182/blood.V96.7.2537
Cahir-McFarland, 2000, NF-κB inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells, Proc Natl Acad Sci U S A, 97, 6055, 10.1073/pnas.100119497
Cahir-McFarland, 2002, NF-κB inhibition in EBV-transformed lymphoblastoid cell lines, Recent Results Cancer Res, 159, 44, 10.1007/978-3-642-56352-2_6
Xu, 2002, Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas, J Virol, 76, 4080, 10.1128/JVI.76.8.4080-4086.2002
Schultheiss, 2001, TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1, EMBO J, 20, 5678, 10.1093/emboj/20.20.5678
Henderson, 1991, Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death, Cell, 65, 1107, 10.1016/0092-8674(91)90007-L
Liu, 2002, The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Iκ B kinase complex, J Biol Chem, 277, 13745, 10.1074/jbc.M110480200
Friborg, 1999, P53 inhibition by the LANA protein of KSHV protects against cell death, Nature, 402, 889, 10.1038/47266
Yoshida, 2001, Multiple viral strategies of HTLV-1 for dysregulation of cell growth control, Annu Rev Immunol, 19, 475, 10.1146/annurev.immunol.19.1.475
Jeang, 2001, Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κB, Cytokine Growth Factor Rec, 12, 207, 10.1016/S1359-6101(00)00028-9
Henderson, 1993, Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death, Proc Natl Acad Sci U S A, 90, 8479, 10.1073/pnas.90.18.8479
Sarid, 1997, Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue, Nat Med, 3, 293, 10.1038/nm0397-293
Cesarman, 2002, Epstein-Barr virus (EBV) and lymphomagenesis, Front Biosci, 7, e58, 10.2741/cesarman
Mamane, 1999, Interferon regulatory factors: the next generation, Gene, 237, 1, 10.1016/S0378-1119(99)00262-0
Lin, 2001, HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators, Oncogene, 20, 800, 10.1038/sj.onc.1204163
Gao, 1997, KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway, Oncogene, 15, 1979, 10.1038/sj.onc.1201571
Barber, 2001, Host defense, viruses and apoptosis, Cell Death Differ, 8, 113, 10.1038/sj.cdd.4400823
Toomey, 2001, Induction of a TRAIL-mediated suicide program with interferon alpha in primary effusion lymphoma, Oncogene, 20, 7029, 10.1038/sj.onc.1204895
Ghosh, 2003, Potentiation of TRAIL induced apoptosis through Azidothymidine mediated inhibition of NF-κB, Blood, 101, 2321, 10.1182/blood-2002-08-2525